TD Cowen Lifts CVS Health Corporation (CVS) Price Target amid Record Q3 Revenue
CVS Health Corporation (NYSE:CVS) is one of the best blue-chip stocks to buy now. On November 3, 2025, TD Cowen lifted its price target on the stock to $100 from $99, while keeping a Buy rating.







